Author

Zofia Novotny

A cancer immunotherapy researcher who began working in laboratory science in 2000, Zofia Novotny runs CAR-T and tumor-model experiments at an academic lab in Boston, Massachusetts. She turned to bench research after briefly considering genetic counseling, holding degrees in molecular biology and biotechnology. A distance runner in her off hours, Novotny covers cancer therapy developments for Biology Insights.

What Is TROP2 and Why Is It a Target in Cancer?
IL4I1: Function in Immune Suppression and Cancer
Bispecific Antibodies for DLBCL: Mechanisms and Applications
What is CD70 and Why is it a Target for Cancer Therapy?
IDO1’s Role in Cancer and the Immune System
What Are SMARCB1-Deficient Cancers?
What is B7-H3 and Its Role in Cancer Therapy?
Tools and Targets in Cancer: Macrophages’ Promising Role
car.m: Breakthrough in Macrophage Cancer Therapy
The Role of HCC Cell Lines in Liver Cancer Research
The Merkel Cell Carcinoma Virus’s Role in Cancer
How Long Do CAR T-Cells Last? Factors in Persistence
pMMR: The Significance of Proficient Mismatch Repair in Cancer
What Is CAR T-Cell Therapy and How Does It Work?
What Are Tumor-Infiltrating Lymphocytes (TILS)?
Omomyc in Cancer Research: Mechanism and Therapeutic Potential
Why Provenge Failed Despite Its Scientific Breakthrough
What Is EPCAM and What Is Its Role in Cancer?
MC38 Cells: A Foundational Model for Cancer Research
The GPC3 Protein: Its Function and Role in Cancer
What Is a PDX Model and How Is It Used in Cancer Research?
What is LAG-3 and Its Role in Cancer Immunotherapy?
CAR T-Cell Therapy Manufacturing Process: A Detailed Look
The Genetic Basis of Triple-Negative Breast Cancer
What Is the CDCP1 Protein and Its Role in Cancer?
DLL3 as a Target in Small Cell Lung Cancer (SCLC)
Allogeneic CAR T-Cell Therapy for Cancer Treatment
What Are Chimeric Antigen Receptors?
U87 Cell: Applications in Brain Cancer Research
LNCaP Cells: A Key Model in Prostate Cancer Research